PL1904522T3 - Sposób oczyszczania G-CSF - Google Patents

Sposób oczyszczania G-CSF

Info

Publication number
PL1904522T3
PL1904522T3 PL06777781T PL06777781T PL1904522T3 PL 1904522 T3 PL1904522 T3 PL 1904522T3 PL 06777781 T PL06777781 T PL 06777781T PL 06777781 T PL06777781 T PL 06777781T PL 1904522 T3 PL1904522 T3 PL 1904522T3
Authority
PL
Poland
Prior art keywords
csf
chromatography
purification
recovery
followed
Prior art date
Application number
PL06777781T
Other languages
English (en)
Other versions
PL1904522T5 (pl
Inventor
Arndt Dietrich
Bernhard Janowski
Jörg Schäffner
Ulrich Kurt Blaschke
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36999964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1904522(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of PL1904522T3 publication Critical patent/PL1904522T3/pl
Publication of PL1904522T5 publication Critical patent/PL1904522T5/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Gyroscopes (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Excavating Of Shafts Or Tunnels (AREA)
  • Graft Or Block Polymers (AREA)
  • Flanged Joints, Insulating Joints, And Other Joints (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL06777781T 2005-07-15 2006-07-14 Sposób oczyszczania G-CSF PL1904522T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005033250A DE102005033250A1 (de) 2005-07-15 2005-07-15 Verfahren zur Reinigung von G-CSF
PCT/EP2006/064263 WO2007009950A1 (de) 2005-07-15 2006-07-14 Verfahren zur reinigung von g-csf
EP06777781.3A EP1904522B2 (de) 2005-07-15 2006-07-14 Verfahren zur reinigung von g-csf

Publications (2)

Publication Number Publication Date
PL1904522T3 true PL1904522T3 (pl) 2009-07-31
PL1904522T5 PL1904522T5 (pl) 2021-01-25

Family

ID=36999964

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06777781T PL1904522T5 (pl) 2005-07-15 2006-07-14 Sposób oczyszczania G-CSF

Country Status (13)

Country Link
US (3) US9815879B2 (pl)
EP (2) EP1904522B2 (pl)
JP (1) JP2009501195A (pl)
AT (1) ATE423131T1 (pl)
CA (2) CA2803048C (pl)
DE (2) DE102005033250A1 (pl)
DK (1) DK1904522T4 (pl)
ES (2) ES2545588T5 (pl)
HU (1) HUE027724T2 (pl)
PL (1) PL1904522T5 (pl)
PT (1) PT1904522E (pl)
SI (1) SI2058326T2 (pl)
WO (1) WO2007009950A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005033250A1 (de) 2005-07-15 2007-01-18 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von G-CSF
KR101741859B1 (ko) 2009-06-22 2017-06-15 암젠 인크 화학적으로 조절된 산화환원 상태를 사용한 단백질의 재폴딩
SI3660032T1 (sl) 2009-06-25 2026-02-27 Amgen Inc. Postopki zajemanja in čiščenja beljakovin, izraženih v nesesalskem sistemu
RS53010B (sr) * 2009-12-31 2014-04-30 Arven Ilac Sanayi Ve Ticaret A.S. Novi postupak za pripremu g-csf (faktora stimulacije kolonije granulocita)
US9867777B2 (en) 2010-01-19 2018-01-16 Hanmi Science Co., Ltd. Liquid formulations for long-acting G-CSF conjugate
WO2011113601A1 (en) * 2010-03-17 2011-09-22 Biogenerix Ag Method for obtaining biologically active recombinant human g-csf
KR101831300B1 (ko) * 2010-10-29 2018-02-23 한미사이언스 주식회사 재조합 대장균으로부터 인간 과립구 콜로니 자극인자를 정제하는 방법
RU2440417C1 (ru) * 2011-01-25 2012-01-20 Тезов Владимир Адольфович Способ очистки рекомбинантного гранулоцитарного колониестимулирующего фактора человека
HUP1200172A2 (en) * 2012-03-19 2013-10-28 Richter Gedeon Nyrt Methods for refolding g-csf from inclusion bodies
WO2016009451A2 (en) * 2014-07-14 2016-01-21 Gennova Biopharmaceuticals Limited A novel process for purification of rhu-gcsf
MA40517A (fr) * 2015-03-16 2016-09-21 Arven Ilac Sanayi Ve Ticaret As Procédé pour préparation du facteur stimulant les colonies de granulocytes (g-csf)
WO2022245259A1 (ru) * 2021-05-18 2022-11-24 Акционерное общество "ГЕНЕРИУМ" Способ промышленной очистки ромиплостима

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4658018A (en) * 1984-03-13 1987-04-14 Immunex Corporation Process for producing homogeneous colony stimulating factor
US4810643A (en) 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
DE3537708A1 (de) 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
DE3729863A1 (de) 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate
CA1340810C (en) 1988-03-31 1999-11-02 Motoo Yamasaki Polypeptide derivatives of human granulocyte colony stimulating factor
FI900178A0 (fi) 1988-05-13 1990-01-12 Amgen Inc Kompositioner och foerfarande foer behandling eller foerhindrande av infektioner hos djur.
ATE111921T1 (de) † 1988-06-03 1994-10-15 Chugai Pharmaceutical Co Ltd Menschlicher kristallinischer granulocyt- koloniestimulierungsfaktor und dessen herstellung.
DE3835350A1 (de) 1988-10-17 1990-04-19 Boehringer Mannheim Gmbh Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern
US5104651A (en) 1988-12-16 1992-04-14 Amgen Inc. Stabilized hydrophobic protein formulations of g-csf
US5055555A (en) † 1989-01-05 1991-10-08 Helmut Sassenfeld Purification of G-CSF
DE4014750A1 (de) 1990-05-08 1991-11-14 Boehringer Mannheim Gmbh Muteine des granulozyten-stimulierenden faktors (g-csf)
FR2669646A1 (fr) 1990-11-23 1992-05-29 Lorraine Laminage Procede de traitement d'un effluent aqueux issu d'un procede d'electrozingage, ainsi que procede et installation en comportant application.
DE4242919A1 (de) 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Verfahren zur Herstellung von lagerstabilen wässrigen pharmazeutischen Zubereitungen von G-CSF
US5331095A (en) † 1993-04-12 1994-07-19 Scios Nova Inc. Process for purification of basic fibroblast growth factor
KR100212071B1 (ko) † 1994-10-08 1999-08-02 유충식 활성형 인 과립구 콜로니 자극인자의 정제방법
KR0160934B1 (ko) † 1996-01-15 1998-11-16 성재갑 효모에서 봉입체로 발현된 재조합 인 과립구 콜로니 자극인자의 정제방법
KR100356140B1 (ko) † 1999-07-08 2002-10-19 한미약품공업 주식회사 인간 과립구 콜로니 자극인자 변이체 및 이의 생산 방법
FR2796071B1 (fr) * 1999-07-08 2001-09-07 Hoechst Marion Roussel Inc Procede de purification de facteur de stimulation de colonies de granulocytes
US6646110B2 (en) † 2000-01-10 2003-11-11 Maxygen Holdings Ltd. G-CSF polypeptides and conjugates
IL152804A0 (en) 2000-05-16 2003-06-24 Bolder Biotechnology Inc Methods for refolding proteins containing free cysteine residues
US20020142964A1 (en) † 2000-11-02 2002-10-03 Nissen Torben Lauesgaard Single-chain polypeptides
WO2002036626A1 (en) † 2000-11-02 2002-05-10 Maxygen Aps Single-chain multimeric polypeptides
SI21102A (sl) * 2001-12-19 2003-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za izolacijo biološko aktivnega granulocitne kolonije stimulirajočega dejavnika
US7118675B2 (en) † 2002-02-04 2006-10-10 Millipore Corporation Process for removing protein aggregates and virus from a protein solution
DK1501369T3 (en) 2002-04-26 2015-09-28 Genentech Inc Non-affinity purification of proteins
AU2002345829A1 (en) * 2002-06-24 2004-01-06 Dr. Reddy's Laboratories Ltd. Process for preparing g-csf
EP1527785A1 (en) * 2003-10-27 2005-05-04 Ludwig-Maximilians-Universität München Use of G-CSF for treating ischemia
CN1663962A (zh) 2004-03-01 2005-09-07 重庆富进生物医药有限公司 重组人粒细胞集落刺激因子及其化学修饰物的一步纯化工艺
DE102004041639A1 (de) * 2004-08-27 2006-03-02 Bioceuticals Arzneimittel Ag Verfahren zur Gewinnung von biologisch aktivem humanen G-CSF aus Inclusion Bodies
EP1869078A2 (en) 2005-03-17 2007-12-26 Zenotech Laboratories Limited Process for the purification of recombinant granulocyte-colony stimulating factor
DE102005033250A1 (de) 2005-07-15 2007-01-18 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von G-CSF

Also Published As

Publication number Publication date
US20080260684A1 (en) 2008-10-23
EP2058326B1 (de) 2015-07-08
ES2545588T3 (es) 2015-09-14
DK1904522T3 (da) 2009-05-25
WO2007009950A1 (de) 2007-01-25
HUE027724T2 (hu) 2016-11-28
ES2322819T5 (es) 2021-02-11
PT1904522E (pt) 2009-05-21
ES2322819T3 (es) 2009-06-29
SI2058326T2 (sl) 2019-09-30
US9815879B2 (en) 2017-11-14
JP2009501195A (ja) 2009-01-15
CA2614820C (en) 2013-04-16
US20210070822A1 (en) 2021-03-11
DK1904522T4 (da) 2020-08-17
EP1904522B1 (de) 2009-02-18
US20180094036A1 (en) 2018-04-05
PL1904522T5 (pl) 2021-01-25
EP1904522B2 (de) 2020-05-27
CA2614820A1 (en) 2007-01-25
US10844103B2 (en) 2020-11-24
EP1904522A1 (de) 2008-04-02
EP2058326B2 (de) 2019-05-15
CA2803048C (en) 2016-09-13
DE502006002897D1 (de) 2009-04-02
DE102005033250A1 (de) 2007-01-18
CA2803048A1 (en) 2007-01-25
ATE423131T1 (de) 2009-03-15
SI2058326T1 (sl) 2015-10-30
ES2545588T5 (es) 2020-02-13
EP2058326A1 (de) 2009-05-13

Similar Documents

Publication Publication Date Title
EA200702210A1 (ru) Способ очистки белков
PL1904522T5 (pl) Sposób oczyszczania G-CSF
NL1026467A1 (nl) Composiet semipermeabel membraan, alsmede productiewerkwijze daarvoor.
EP1808220A4 (en) METHOD FOR PRODUCING A REVERSE OSOMOSIS COMPOUND MEMBRANE
WO2008031020A3 (en) Arginine wash in protein purification using affinity chromatography
WO2013051368A3 (ja) フィルタ及び空気清浄機
WO2005065126A3 (en) Blood filter assembly having multiple filtration regions
EP2067520A4 (en) METHOD FOR OPERATING A REVERSE OSMOSEMBRANE FILTRATION PLANT AND REVERSE OSMOSEMBRANE FILTRATION PLANT
AU2003275700A1 (en) Composite adsorbent and method for production thereof, and water purification material and water purifier
EP1820566A4 (en) SEMI-PERMEABLE COMPOSITE MEMBRANE AND PROCESS FOR PRODUCTION OF SAID MEMBRANE
EP1759754A4 (en) FILTER, METHOD FOR THE PRODUCTION THEREOF AND EXHAUST GAS CLEANING SYSTEM
PL2305361T3 (pl) System oczyszczania gazu
WO2003008337A3 (en) Apparatus and method for softening water by nanofiltration
DE502005006305D1 (de) Kondensatfilter, insbesondere für Luftaufbereitungsmodule
GB2393196A8 (en) Two stage filter assembly
ATE330688T1 (de) Filterelement zum filtrieren von fluiden
BRPI0813823B8 (pt) métodos para concentração de uma solução de imunoglobulina por filtração de fluxo tangencial, e para produção de uma imunoglobulina
BR0311171A (pt) Instalação de filtro
EP1825905A4 (en) SEMI-PERMEABLE COMPOSITE MEMBRANE AND PROCESS FOR PRODUCTION OF SAID MEMBRANE
DE50312951D1 (pl)
ATE419135T1 (de) Verfahren zum reinigen von atmosphärenluft
WO2009063069A3 (en) Protein purification and endotoxin removal
DK1999262T3 (da) Fremgangsmåde til rensning af rekombinant alfa 1-antitrypsin omfattende et anionbytterchromatografitrin
WO2004060794A3 (en) Molecular sieve ssz-63
DE112004000542D2 (de) Trennsäule, insbesondere für einen miniaturisierten Gaschromatographen